Welcome to the international HTA database

Showing [20545 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2009	HAYES, Inc.	Stimulants for Attention-Deficit/Hyperactivity Disorder (ADHD) in children
2006	National Institute for Health and Clinical Excellence (NICE)	Stimulated graciloplasty for faecal incontinence
2000	Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT)	Stimulation in Parkinson's disease - systematic review, expert panel
2013	Institute of Health Economics (IHE)	Stingray catheter and guidewire for recanalization of coronary chronic total occlusions: a rapid evidence assessment
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Stiripentol (Diacomit — Biocodex SA) indication: severe myoclonic epilepsy in infancy (Dravet syndrome)
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Stiripentol (Diacomit®) for use in conjunction with clobazam and valproate in patients with severe myoclonic epilepsy in infancy
2000	The Swedish Council on Health Technology Assessment (SBU)	Stomach pain - evidence-based methods in the diagnosis and treatment of dyspepsia
2010	HAYES, Inc.	Stone cone nitinol retrieval coil (Boston Scientific Corp.) to prevent retrograde migration of ureteral calculi during intracorporeal lithotripsy
2008	NIHR Health Technology Assessment programme	STOOL - Stepped Treatment of Older adults On Laxatives - Primary Research
2015	Canadian Agency for Drugs and Technologies in Health (CADTH)	Stool antigen tests for helicobacter pylori infection: a review of clinical and cost-effectiveness and guidelines
2021	Austrian Institute for Health Technology Assessment (AIHTA)	Stool DNA testing for colorectal cancer (CRC) screening
2019	European Network for Health Technology Assessment (EUnetHTA)	Stool DNA testing for early detection of colorectal cancer
2004	Institute for Clinical Effectiveness and Health Policy (IECS)	Storage of cord blood hematopoietic stem cells
2004	Agency for Healthcare Research and Quality (AHRQ)	Strategies for improving minority healthcare quality
2016	Agency for Healthcare Research and Quality (AHRQ)	Strategies for improving the lives of women aged 40 and above living with HIV/AIDS.
2021	Health Technology Wales (HTW)	Strategies for Relatives (START) intervention to improve the mental health of carers of people with dementia
2009	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	Strategies for the diffusion and dissemination of health technology assessment (HTA) products
2017	Center for Evidence-based Practice (CEP)	Strategies for transitioning adult medical-surgical inpatients with a need for mental health services to outpatient settings
2016	Agency for Healthcare Research and Quality (AHRQ)	Strategies to de-escalate aggressive behavior in psychiatric patients
2020	Malaysian Health Technology Assessment (MaHTAS)	Strategies to eliminate mother to child transmission of hepatitis B in Malaysia
2017	Agency for Healthcare Research and Quality (AHRQ)	Strategies to improve mental health care for children and adolescents
2010	National Institute for Health and Clinical Excellence (NICE)	Strategies to prevent unintentional injuries among under-15s
2013	Agency for Healthcare Research and Quality (AHRQ)	Strategies to prevent weight gain among adults
2012	Agency for Healthcare Research and Quality (AHRQ)	Strategies to reduce cesarean birth in low-risk women
2006	Alberta Heritage Foundation for Medical Research (AHFMR)	Strategies to reduce emergency department overcrowding
2006	Haute Autorite de sante (HAS)	Strategy for early diagnosis of melanoma
2000	L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES)	Strategy for management of type 2 diabetics, excluding management of complications
2018	NIHR Health Technology Assessment programme	Strategy of endovascular versus open repair for patients with clinical diagnosis of ruptured abdominal aortic aneurysm: the IMPROVE RCT
2020	NIHR Health Technology Assessment programme	Stratified Care for Patients with Sciatica and Suspected Sciatica in Primary Care: a randomised trial (the SCOPiC trial - SCiatica Outcomes in Primary Care)
2015	NIHR Health Technology Assessment programme	Strengthening And stretching for Rheumatoid Arthritis of the Hand (SARAH). A randomised controlled trial and economic evaluation
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Strengthening the evidence base for a learning health system - Inspirations from good practice for capacity building in health services research and public health research
2010	Medical Advisory Secretariat (MAS)	Stress echocardiography for the diagnosis of coronary artery disease
2010	Medical Advisory Secretariat (MAS)	Stress echocardiography with contrast for the diagnosis of coronary artery disease
1992	The Swedish Council on Health Technology Assessment (SBU)	Stroke
2005	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Stroke clinical practice guideline
2007	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Stroke clinical practice guideline (update January 2007)
2013	Agency for Healthcare Research and Quality (AHRQ)	Stroke prevention in atrial fibrillation
1992	University of York	Stroke rehabilitation
1999	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Stroke rehabilitation
2003	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Stroke rehabilitation services: systematic reviews of the clinical and economic evidence.
2020	NIHR Health Services and Delivery Research programme	Stroke Sentinel Audit Programme: Investigating and Evaluating Stroke Therapy (SSNAPIEST)
2012	Belgian Health Care Knowledge Centre (KCE)	Stroke units: efficacy, quality indicators and organisation
2004	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	Stroke Units: update of HTA report "Assessment of stroke units as medical techology"
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Strokefinder MD100 microwave tomography for early diagnosis of stroke type
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Strontium ranelate (Protelos) for osteoarthritis
2003	NIHR Horizon Scanning Centre (NIHR HSC)	Strontium ranelate for osteoporosis - horizon scanning review
2007	NIHR Health Technology Assessment programme	Strontium ranelate for the prevention of osteoporotic fractures in post-menopausal women with osteoporosis
2008	NIHR Health Technology Assessment programme	Structural brain imaging in first episode psychosis
2008	Quality Improvement Scotland (NHS QIS )	Structural neuroimaging in first episode psychosis
2008	National Institute for Health and Clinical Excellence (NICE)	Structural neuroimaging in first-episode psychosis
2008	NIHR Health Technology Assessment programme	Structural neuroimaging in psychosis: a systematic review and economic evaluation
2018	Health Quality Ontario (HQO)	Structured Education and Neuromuscular Exercise Program for Hip and/or Knee Osteoarthritis: A Health Technology Assessment
2018	NIHR Health Technology Assessment programme	Structured lifestyle education to support weight loss for people with schizophrenia, schizoaffective disorder and first episode psychosis: the STEPWISE RCT
2022	Center for Evidence-based Practice (CEP)	Structured screening questionnaires for alcohol misuse/alcohol use disorders
2015	NIHR Health Technology Assessment programme	Structured telephone support or telemonitoring programmes for patients with chronic heart failure
2014	NIHR Health Technology Assessment programme	Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation the CASCADE study
2002	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	Studies and scales used in technologies within the orthoprosthetic benefits. IPE-02/33 (Public report)
2013	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	Study of adherence to Recombinant Growth Hormone treatment of children with a GH deficiency: contributions to treatment control and economic impact
1999	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Study of the appropriateness of prescribing antibiotic treatments in primary care and costs derived from inappropriateness
2004	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Study of the factors that may explain the differences in population prevalence and in hospitalised patients due to mental disorders by territory
2013	NIHR Health Technology Assessment programme	Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
1998	TNO	Study of waiting lists in mental primary care (AGGZ)
2005	Agency for Healthcare Research and Quality (AHRQ)	Study on Regulation of Health Care: The Impact of Regulation on the Health Insurance Market and Health Care Providers
2005	NIHR Horizon Scanning Centre (NIHR HSC)	SU11248 for 2nd-line treatment of gastrointestinal stromal tumour (GIST) in patients refractory or intolerant of imatinib mesylate - horizon scanning review
2005	NIHR Horizon Scanning Centre (NIHR HSC)	SU11248 for metastatic renal cell carcinoma (Stage IV) - horizon scanning review
2021	Swiss Federal Office of Public Health (FOPH)	Subacromial decompression as a primary/isolated intervention to treat subacromial pain
2021	Norwegian Institute of Public Health (NIPH)	Subacromial decompression surgery for impingement syndrome: rapid health technology assessment
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subcutaneous administration of proton pump inhibitors in palliative care patients: a review of clinical effectiveness and guidelines
2012	Medical Services Advisory Committee (MSAC)	Subcutaneous Immunoglobulins (SCIg)
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subcutaneous immunotherapy for the treatment of allergies: a review of the clinical efficacy, safety and guidelines
2018	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Subcutaneous implantable cardioverter defibrillator (ICD)
2017	HAYES, Inc.	Subcutaneous implantable cardioverter defibrillator (S-ICD) for prevention of sudden cardiac death
2010	Adelaide Health Technology Assessment (AHTA)	Subcutaneous implantable cardioverter-defibrillator (ICD) for patients at risk of sudden cardiac death
2022	Austrian Institute for Health Technology Assessment (AIHTA)	Subcutaneous implantable cardioverter-defibrillator (S-ICD). Update 2022
2010	HAYES, Inc.	Subcutaneous implantation of estradiol pellets for postmenopausal disorders
2011	HAYES, Inc.	Subcutaneous implantation of estradiol pellets for postmenopausal disorders
2012	HAYES, Inc.	Subcutaneous implantation of estradiol pellets for postmenopausal disorders
2017	NIHR Health Technology Assessment programme	Subcutaneous Injection of Adalimumab Trial compared with Control (SCIATiC): a randomised controlled trial of adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subcutaneous lidocaine in community care: a review of the guidelines and patient safety
2007	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subcutaneous open-loop insulin delivery for type 1 diabetes: Paradigm (TM) real-time system
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Subcutaneous tocilizumab for juvenile idiopathic polyarthritis – second line
2008	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subcutaneous versus intravenous immunoglobulin for primary immunodeficiencies: systematic review and economic evaluation
2004	National Institute for Clinical Excellence (NICE)	Subfascial endoscopic perforator vein surgery
2011	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Subglottic secretion drainage endotracheal tubes for prevention of ventilator-associated pneumonia
2001	NIHR Health Technology Assessment programme	Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives
2003	Blue Cross Blue Shield Association (BCBS)	Sublingual immunotherapy for adults
2011	HAYES, Inc.	Sublingual immunotherapy for allergic rhinitis
2009	HAYES, Inc.	Sublingual immunotherapy for allergic rhinitis and asthma
2004	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Submandibular gland transfer for preservation of salivary function
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suboxone for short-term detoxification: a review of the clinical evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suboxone for the treatment of chronic non-cancer pain: clinical effectiveness and guidelines
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suboxone versus methadone for the detoxification of patients addicted to prescription opioids: a review of comparative clinical effectiveness, safety, and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suboxone versus methadone for the treatment of opioid dependence: a review of the clinical and cost-effectiveness
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subsequent entry biologics — emerging trends in regulatory and health technology assessment frameworks
2017	Adelaide Health Technology Assessment (AHTA)	Substitution of 68-Ga-DOTA-peptide PET/CT scanning in lieu of Octreotide for patients undergoing somatostatin receptor diagnostic imaging under MBS item 61369
2012	HAYES, Inc.	Subtalar arthroereisis for the treatment of flatfoot
2009	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Subthalamic deep brain stimulation (DBS): clinical efficacy, safety and cost compared to medical therapy for the treatment of Parkinson's Disease
2004	National Institute for Clinical Excellence (NICE)	Subthalamotomy for Parkinson's disease
2003	Wessex Institute for Health Research and Development (WIHRD)	Successive attempts at in vitro fertilization
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Sucroferric oxyhydroxide (Velphoro®)